TrialHaematologica2013

Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia.

Clifton C Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.